Work

A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy

Year: 2013

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2013.04.049

Authors: Robert M. Wenham, James Lapolla, Hui-Yi Lin, Sachin M. Apte, Johnathan M. Lancaster, Patricia L. Judson, Jesus Gonzalez-Bosquet, Amber Herschberger, Laura J. Havrilesky, Angeles Alvarez Secord

Institutions: Moffitt Cancer Center, Duke University, Duke Medical Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Sanofi, Genentech, National Cancer Institute

Award: Moffitt Cancer Center Support Grant

OpenAlex ID: W2000390031

FWCI: 6.003

Cites: 60

Cited by: 29

Related to: 10